in this issue
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
Pharma/fine chemicals roundup—7 May
8:54 AM MDT | May 7, 2013 | Deepti Ramesh
Teva’s API business reports fall in sales The active pharmaceutical ingredient (API) business of Teva Pharmaceutical Industries (Petaḥ Tiqwa, Israel), recorded a 6.5% fall in sales in the first quarter compared with the year-ago quarter, to $186 million. Teva has the largest API business in the world in terms of sales. Vertellus upgrades Belgium facility for API niacin manufacture Vertellus Specialties (Indianapolis) says that its facility at Antwerp has completed capital and other upgrades for the manufacture of niacin, or nicotinic acid, for...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee